Renal denervation for resistant hypertension?

New England Journal of Medicine

Volumn 370, Issue 15, 2014, Pages 1454-1457

  Messerli, Franz H ^a   Bangalore, Sripal ^b  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; SPIRONOLACTONE;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MEASUREMENT; BORDERLINE HYPERTENSION; CLINICAL EFFECTIVENESS; EDITORIAL; HUMAN; HYPERTENSION; INTERVENTION STUDY; KIDNEY DENERVATION; MEDICAL SOCIETY; PLACEBO EFFECT; PRIORITY JOURNAL; PUBLICATION; RESISTANT HYPERTENSION; SYSTOLIC BLOOD PRESSURE;

DENERVATION; FEMALE; HUMANS; HYPERTENSION; MALE; RENAL ARTERY;

EID: 84898720409     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1402388     Document Type: Editorial

References (10)

1. Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD. Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med 2009;361:932-4.
2. Messerli FH, Bangalore S. Treatment-resistant hypertension: another Cinderella story. Eur Heart J 2013;34:1175-7.
3. Radio waves to kidneys lower persistent high blood pressure. Press release of the American Heart Association, Dallas, December 17, 2012.
4. Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 2009; 373:1275-81.
5. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M. Renal sympathetic denervation in patients with treatment-resistant hypertension (the SYMPLICITY HTN-2 Trial): a randomised controlled trial. Lancet 2010;376:1903-9.
6. Krum H, Schlaich MP, Sobotka PA, et al. Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the SYMPLICITY HTN-1 study. Lancet 2014; 383:622-9. [Erratum, Lancet 2014;383:602.]
7. Bhatt DL, Kandzari DE, O'Neill WW, et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med 2014;370:1393-401.
8. Elmula F, Hoffmann P, Larstorp AC, et al. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension. Hypertension 2014 March 3 (Epub ahead of print).
9. Gottlieb S. The FDA wants you for sham surgery: there are better ways to test medical devices than by having patients be placebos who get fake operations. Wall Street Journal. February 18, 2014.
10. Mahfoud F, Bhatt DL. Catheter-based renal denervation: the black box procedure. JACC Cardiovasc Interv 2013;6:1092-4.